223 related articles for article (PubMed ID: 15455792)
1. [A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis].
Chaigne V; Knefati Y; Lafarge R; Bronner J; Mc Gregor B; Fouque D; Sabatier JC
Nephrologie; 2004; 25(5):179-83. PubMed ID: 15455792
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
[TBL] [Abstract][Full Text] [Related]
4. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
[TBL] [Abstract][Full Text] [Related]
5. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
[TBL] [Abstract][Full Text] [Related]
6. [Fever, pancytopenia, and splenomegaly 8 months after a trip to Majorca Island (Spain)].
Lübbert C; Opitz BM; Harms-Zwingenberger G; Nietsch HH
Med Klin (Munich); 2008 Jan; 103(1):29-35. PubMed ID: 18219460
[TBL] [Abstract][Full Text] [Related]
7. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil.
Oliveira RA; Silva LS; Carvalho VP; Coutinho AF; Pinheiro FG; Lima CG; Leandro JE; Silva GB; Daher EF
Transpl Infect Dis; 2008 Oct; 10(5):364-8. PubMed ID: 18507750
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
[TBL] [Abstract][Full Text] [Related]
9. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE
Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
11. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Manfredi R; Marinacci G; Calza L; Passarini B
Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
[No Abstract] [Full Text] [Related]
12. [Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS].
Navarro M; Bonet J; Bonal J; Romero R
Nefrologia; 2006; 26(6):745-6. PubMed ID: 17227255
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
[TBL] [Abstract][Full Text] [Related]
15. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
16. Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient.
Enríquez R; Sirvent AE; Padilla S; Toro P; Sánchez M; Millán I
Am J Case Rep; 2015 Jan; 16():8-11. PubMed ID: 25575099
[TBL] [Abstract][Full Text] [Related]
17. Membranoproliferative Glomerulonephritis and Mixed Cryoglobulinemia as a Form of Presentation of Visceral Leishmaniasis.
Padrón Romero M; Acevedo Ribó MM; Ahijado Hormigos FJ; Díaz Crespo F; Cueto Bravo L; Herraiz Corredor C; Fernández Rojo MÁ; Díaz-Tejeiro Izquierdo R
Am J Case Rep; 2020 May; 21():e921445. PubMed ID: 32459796
[TBL] [Abstract][Full Text] [Related]
18. Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician.
Maggi P; Gaudiano V; Valente M; Latorraca A; Cavaliere RL; Marroni M; Larocca AM; Stagni G; Lopez T; Pastore G
J Nephrol; 2004; 17(2):296-301. PubMed ID: 15293532
[TBL] [Abstract][Full Text] [Related]
19. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C
BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
Colakoglu M; Fidan Yaylali G; Yalcin Colakoglu N; Yilmaz M
Scand J Infect Dis; 2006; 38(3):208-10. PubMed ID: 16500783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
